Skip to main
CME

CME Group (CME) Stock Forecast & Price Target

CME Group (CME) Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 17%
Buy 33%
Hold 33%
Sell 17%
Strong Sell 0%

Bulls say

CME Group has demonstrated strong financial performance, achieving record quarterly revenue of $1.7 billion, reflecting a 10% year-over-year increase, primarily driven by exceptional growth in Clearing & Transaction and Market Data revenue. The company's expansion into new markets and asset classes is evidenced by a significant increase in retail traders, with over 90,000 new additions, representing a 56% year-over-year growth, and record international volumes in EMEA and APAC regions, up 15% and 30% respectively. Additionally, the strategic partnerships and acquisitions, including the stakes in S&P Dow Jones Indices and NEX, position CME Group for ongoing revenue growth and enhanced capital efficiency amid favorable market conditions such as rising interest rates.

Bears say

CME Group faces a negative outlook due to the potential for a decline in open interest, which could signal deteriorating market sentiment and negatively impact the company's share performance. The company's heavy dependence on market volumes makes it susceptible to fluctuations in market volatility, especially given the current geopolitical tensions and uncertainty related to tariff impacts that may affect trading activity. Additionally, increased regulatory oversight and competitive pressures could adversely affect revenues and earnings, posing further risks to CME's financial stability.

CME Group (CME) has been analyzed by 12 analysts, with a consensus rating of Hold. 17% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 17% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CME Group (CME) Forecast

Analysts have given CME Group (CME) a Hold based on their latest research and market trends.

According to 12 analysts, CME Group (CME) has a Hold consensus rating as of Jan 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $286.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $286.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CME Group (CME)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.